^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IL-17E

    i
    Other names: IL-17E, IL-25, interleukin-17E
    Associations

    News

    Trials
    Company:
    Aptose Biosci
    Drug class:
    Apoptosis stimulant, Immunomodulator
    Related drugs:
    Associations

    News

    Trials
    4years
    Dihydromyricetin inhibited ovalbumin-induced mice allergic responses by suppressing the activation of mast cells. (PubMed, Food Funct)
    Furthermore, DMY blocked the high affinity IgE receptor (FcεRI)-IgE interaction, inhibited the release of β-hexosaminidase and histamine in rat basophilic leukemia-2H3 cells, and alleviated passive cutaneous anaphylaxis reactions. These findings indicated that L. pauciflorus derived DMY might have the potential to alleviate food hypersensitivity or allergic diseases.
    Preclinical • Journal
    |
    IL10 (Interleukin 10)
    |
    IL-17E